HK8580A - New form of flunisolide and the use of flunisolide to treat respiratory diseases - Google Patents
New form of flunisolide and the use of flunisolide to treat respiratory diseasesInfo
- Publication number
- HK8580A HK8580A HK85/80A HK8580A HK8580A HK 8580 A HK8580 A HK 8580A HK 85/80 A HK85/80 A HK 85/80A HK 8580 A HK8580 A HK 8580A HK 8580 A HK8580 A HK 8580A
- Authority
- HK
- Hong Kong
- Prior art keywords
- flunisolide
- respiratory diseases
- new form
- treat respiratory
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58130075A | 1975-05-27 | 1975-05-27 | |
US58130175A | 1975-05-27 | 1975-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK8580A true HK8580A (en) | 1980-03-14 |
Family
ID=27078279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK85/80A HK8580A (en) | 1975-05-27 | 1980-03-06 | New form of flunisolide and the use of flunisolide to treat respiratory diseases |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS51144719A (sv) |
AT (1) | AT357702B (sv) |
AU (1) | AU506080B2 (sv) |
CA (1) | CA1075228A (sv) |
DE (2) | DE2661037C2 (sv) |
ES (1) | ES448220A1 (sv) |
FR (1) | FR2361900A1 (sv) |
GB (1) | GB1525181A (sv) |
HK (1) | HK8580A (sv) |
IL (1) | IL49652A (sv) |
MX (1) | MX3864E (sv) |
MY (1) | MY8000275A (sv) |
NL (1) | NL191234C (sv) |
NZ (1) | NZ180946A (sv) |
SE (1) | SE421426B (sv) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK162530C (da) * | 1979-05-21 | 1992-03-30 | Syntex Corp | Fremgangsmaade til fremstilling af en krystallinsk modifikation af flunisolid |
ATE3774T1 (de) * | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. |
GB2127689B (en) * | 1982-10-05 | 1986-07-09 | Sandoz Ltd | Calcitonin inhalation compositions |
US4782047A (en) * | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
US5707634A (en) * | 1988-10-05 | 1998-01-13 | Pharmacia & Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
HU209603B (en) * | 1988-10-05 | 1994-09-28 | Upjohn Co | Process for production of solid powders in finalydivided microcristallin form |
DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
ES2183001T3 (es) * | 1995-06-27 | 2003-03-16 | Boehringer Ingelheim Pharma | Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor. |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
AU766410B2 (en) * | 1999-03-03 | 2003-10-16 | Optinose As | Nasal delivery device |
IT1313553B1 (it) * | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
CZ303833B6 (cs) | 2000-05-22 | 2013-05-22 | Chiesi Farmaceutici S.P.A. | Aerosolový prostredek |
DE60103527T2 (de) | 2001-07-02 | 2005-06-16 | Chiesi Farmaceutici S.P.A. | Optimierte Tobramycin-Formulierung zur Aerosolbildung |
JP4632687B2 (ja) * | 2003-04-25 | 2011-02-16 | ロート製薬株式会社 | 点鼻剤 |
JP5238779B2 (ja) * | 2003-04-25 | 2013-07-17 | ロート製薬株式会社 | 点鼻剤 |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
CA2905587A1 (en) * | 2013-03-15 | 2014-09-18 | Medicis Pharmaceutical Corporation | Topical compositions of flunisolide and methods of treatment |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3126375A (en) * | 1964-03-24 | Chioacyl | ||
GB933867A (en) * | 1958-12-08 | 1963-08-14 | American Cyanamid Co | Fluorinated steroids |
US3282791A (en) * | 1965-08-17 | 1966-11-01 | Merck & Co Inc | Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate |
US3592930A (en) * | 1968-07-19 | 1971-07-13 | Syntex Corp | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle |
DE2015300A1 (de) * | 1969-04-01 | 1970-10-29 | Syntex Corp., Panania;PM | örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung |
GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
DE2332663C2 (de) * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie |
US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
-
1976
- 1976-05-14 MX MX76234U patent/MX3864E/es unknown
- 1976-05-25 SE SE7605927A patent/SE421426B/sv not_active IP Right Cessation
- 1976-05-25 ES ES448220A patent/ES448220A1/es not_active Expired
- 1976-05-25 CA CA253,267A patent/CA1075228A/en not_active Expired
- 1976-05-25 NZ NZ180946A patent/NZ180946A/xx unknown
- 1976-05-25 IL IL49652A patent/IL49652A/xx unknown
- 1976-05-26 AT AT388376A patent/AT357702B/de not_active IP Right Cessation
- 1976-05-26 AU AU14301/76A patent/AU506080B2/en not_active Expired
- 1976-05-26 NL NL7605699A patent/NL191234C/xx not_active IP Right Cessation
- 1976-05-26 GB GB21936/76A patent/GB1525181A/en not_active Expired
- 1976-05-26 FR FR7616040A patent/FR2361900A1/fr active Granted
- 1976-05-26 JP JP51061032A patent/JPS51144719A/ja active Granted
- 1976-06-03 DE DE2661037A patent/DE2661037C2/de not_active Expired
- 1976-06-03 DE DE2624924A patent/DE2624924C2/de not_active Expired
-
1980
- 1980-03-06 HK HK85/80A patent/HK8580A/xx unknown
- 1980-12-30 MY MY275/80A patent/MY8000275A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MY8000275A (en) | 1980-12-31 |
MX3864E (es) | 1981-08-26 |
JPS51144719A (en) | 1976-12-13 |
DE2624924A1 (de) | 1977-12-15 |
SE421426B (sv) | 1981-12-21 |
ES448220A1 (es) | 1977-11-01 |
IL49652A (en) | 1979-05-31 |
NZ180946A (en) | 1978-07-28 |
FR2361900A1 (fr) | 1978-03-17 |
AU506080B2 (en) | 1979-12-13 |
SE7605927L (sv) | 1976-11-28 |
DE2624924C2 (de) | 1986-11-27 |
IL49652A0 (en) | 1976-07-30 |
FR2361900B1 (sv) | 1979-04-13 |
GB1525181A (en) | 1978-09-20 |
NL7605699A (nl) | 1976-11-30 |
CA1075228A (en) | 1980-04-08 |
ATA388376A (de) | 1979-12-15 |
DE2661037C2 (sv) | 1989-04-06 |
AT357702B (de) | 1980-07-25 |
NL191234C (nl) | 1995-04-03 |
NL191234B (nl) | 1994-11-01 |
AU1430176A (en) | 1977-12-01 |
JPS6247880B2 (sv) | 1987-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY8000275A (en) | New form of flunisolide and the use of flunisolide to treat respiratory diseases | |
JPS5233399A (en) | Patient*s respirator | |
GB1550835A (en) | Treatment of tobacco | |
PT65554B (en) | Laminate and process of its manufacture | |
JPS5228193A (en) | Selffcontained personal respirator | |
ZA754725B (en) | Preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use | |
ZA764855B (en) | Treatment of pigment | |
PH13782A (en) | Therapeutic treatment of dry skin | |
JPS5246387A (en) | Catalyst composites and manufacture of thereof | |
ZA763339B (en) | Treatment of pigment | |
GB1368201A (en) | Treatment of diseases of the skin and mucosa | |
ZA762669B (en) | Treatment of neoplasias | |
ZA763340B (en) | Treatment of pigment | |
ZA708400B (en) | Improvements relating to the treatment of obstructive diseases of the respiratory tract | |
ZA763131B (en) | Use of flunisolide to treat respiratory diseases | |
MY8800128A (en) | Preparation of post-masectomy treatment medicant | |
ZA763076B (en) | Improvements in and relating to the manufacture of coke | |
ZA781161B (en) | Treatment of asthma | |
PH13398A (en) | Use of flunisolide to treat respiratory diseases | |
JPS5242997A (en) | Treatment of wool | |
MY8400150A (en) | Rosenthale and alphonse dervins inhalation therapy | |
PH11010A (en) | Therapeutic composition for the treatment of mycobacterioses and method of use thereof | |
ZA765293B (en) | Treatment of electrodes | |
GB1486641A (en) | Preparation and use of rho-phenylenediamines | |
JPS5253893A (en) | Production of cephalosporin and use of same as medicine |